Cargando...

Monitoring Toxicity, Impact, and Adherence of Hydroxyurea in Children with Sickle Cell Disease

Hydroxyurea (HU) is underutilized in sickle cell disease (SCD). Patient adherence with taking HU and with required drug monitoring is a provider perceived barrier to HU utilization.(1-4) To determine process issues that may contribute to these barriers we sought to: 1) describe how providers monitor...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Brandow, Amanda M., Panepinto, Julie A.
Formato: Artigo
Idioma:Inglês
Publicado: 2011
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3804029/
https://ncbi.nlm.nih.gov/pubmed/21815183
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.22101
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!